Información de la revista
Visitas
97
Original Article
Acceso a texto completo
Pruebas no corregidas. Disponible online el 3 de julio de 2025
Study of Risk Factors for the Presence of Interdigital Nevi of the Feet
Estudio de los factores de riesgo de la presencia de los nevus interdigitales de los pies
Visitas
97
V. Sánchez-Garcíaa,
Autor para correspondencia
sanchez_veronicagar@gva.es

Correponding author.
, M. Senent-Valeroa, B. Mexía Beldab, E. Nagorec, J. Bañulsa,d
a Servicio de Dermatología, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
b Centro de Salud los Alpes, Madrid, Spain
c Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, Spain
d Departamento de Medicina Clínica, Universidad Miguel Hernández, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
Contenido relacionado
V. Sánchez-García, M. Senent-Valero, B. Mexía Belda, E. Nagore, J. Bañuls
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (3)
Table 1. Descriptive, bivariate, and multivariate analysis of the patient sample (n=255).
Tablas
Table 2. Correlation study between the number of interdigital nevi (outcome variable) and the number of nevi on the sole and dorsum of the feet (explanatory variables).
Tablas
Table 3. Comparison of the bivariate analysis results from our study with findings from the literature.
Tablas
Mostrar másMostrar menos
Figuras (1)
Abstract
Background and objectives

No studies focused on counting the interdigital acquired melanocytic nevi (AMN) of the foot (IDNf) have ever been conducted. Therefore, our objective was to study the relationship between the presence of IDNf and the total number of AMN in the feet and the rest of the body, the racial phenotypic characteristics, and other risk factors for melanoma.

Material and methods

We conducted a cross-sectional observational study with 255 patients ≥18 years old who attended our Dermatology Unit from September 2020 through February 2021, and included all AMN ≥1mm from the feet and ≥2mm from the rest of the bod. The association between the variables was studied using univariate and multivariate logistic regression models.

Results

The presence of IDNf was significantly and independently associated with the presence of plantar AMN and body counts ≥50 AMN. However, no significant differences were observed regarding sex, age, personal history of melanoma, presence of nevi on the dorsum of the foot, history of sunburn or UV rays, or racial phenotypic characteristics.

Conclusions

The presence of IDNf is associated with a higher count of plantar nevi and total AMN in the body, meaning that interdigital spaces of the foot – anatomical expansions of the sole and other possibly genetic causes – could be responsible for the number of AMN found in this location, as these regions are not photoexposed.

Keywords:
Melanocytic nevi
Interdigital nevi
Plantar nevi
Acral nevi
Nevi count
Resumen
Antecedentes y objetivos

Existe una ausencia de estudios centrados en el recuento de nevus melanocíticos adquiridos (NMA) interdigitales de los pies (NIDp). Nuestro objetivo fue estudiar la relación de la presencia de NIDp con el número total de NMA de los pies y del resto del cuerpo, las características fenotípicas raciales y otros factores de riesgo de melanoma.

Material y métodos

Se realizó un estudio observacional transversal que incluyó a 255 pacientes, ≥18 años, que acudieron a nuestro servicio de Dermatología desde septiembre de 2020 a febrero de 2021. Se registraron todos los NMA ≥1mm de los pies y ≥2mm del resto del cuerpo. Se estudió la asociación entre las variables mediante un modelo de regresión logística uni- y multivariante.

Resultados

La presencia de NIDp se asoció de manera estadísticamente significativa e independiente con la presencia de NMA plantares y con recuentos de ≥50 NMA en el cuerpo. Sin embargo, no se observaron diferencias significativas respecto al sexo, la edad, los antecedentes personales de melanoma, la presencia de nevus en el dorso de los pies, antecedentes de quemaduras solares o rayos UVA, ni con características fenotípicas raciales.

Conclusiones

La presencia de NIDp se relaciona con un mayor recuento de nevus plantares y NMA totales del cuerpo, lo que puede significar que los espacios interdigitales son una expansión anatómica de la planta del pie y que otras causas, posiblemente genéticas, serían responsables del número de NMA en esta localización, al ser zonas nada fotoexpuestas.

Palabras clave:
Nevus melanocíticos
Nevus interdigitales
Nevus plantares
Nevus acral
Recuento de nevus
Resumen gráfico
Texto completo
Introduction

Acquired melanocytic nevi (AMN) are benign tumors of melanocytes considered the most common benign neoplasms in the white population.1 It is well known that the number of AMN is one of the most important risk factors for developing melanoma.2

Although most AMN are usually located in sun-exposed (SE) areas, they also appear in less-exposed sites such as the palms or soles, and these are known as acral AMN.3 Publications reporting counts of these AMN are quite scarce.3–13 Their pathogenesis is unknown, and they display a different mutational profile vs non-acral nevi and acral lentiginous melanoma (ALM).14 On the other hand, the possible association between ALM and acral AMN is controversial.13,15,16

However, there are no studies characterizing AMN in the interdigital spaces, an area especially hidden from SE. Although this location is a transitional zone between the dorsum and the sole of the feet, it is unclear whether the presence of AMN in interdigital spaces can be equated to those located in either of these two areas, or whether there is any relationship with the number of nevi on the rest of the body.

The aim of the present study was to observe whether the count of interdigital nevi of the feet (IDNf) was associated with the total number of AMN on the foot, and other risk factors for developing melanoma, such as the total number of AMN of the body (AMN-B), racial phenotypic characteristics, and a history of UV radiation (UVR) exposure.15

Material and methods

We designed a cross-sectional observational study including all adult patients (≥18 years) who attended the pigmented lesion clinic of the Dermatology Department at Hospital General Universitario de Alicante (GUHA) from September 2020 through February 2021. Patients with Fitzpatrick skin types I to IV5 were selected, and those meeting any of the following exclusion criteria were excluded: presence of giant congenital nevi, severe mental illness or poor hygiene conditions that prevented examination of the feet.

The study protocol was conducted in full compliance with the principles of the Declaration of Helsinki and approved by the GUHA Ethics Committee (Act 2021-03).

Study variables

The outcome variable was the number of interdigital AMN ≥1mm on the feet.

The following explanatory variables were considered: sex, age, eye color (light [blue or green] and dark [brown or black]); hair color at age 20 (light [red, blond, or light brown], dark [dark brown or black]); skin phototype (light [I and II] or dark [III and IV]), presence of freckles, personal history of severe sunburn (defined as blistering after sun exposure), personal history of melanoma, non-melanoma skin cancer (NMSC), and non-skin cancer, use of UVA lamp, number of AMN-B ≥2mm (≤50 and >50), number of AMN ≥1mm on the sole (AMN-S) and dorsum of the feet (AMN-D), referencing those underneath the malleoli.

Regarding the cutoff point for considering acral AMN, including IDNf, we chose ≥1mm as the minimum size to avoid confusion with other lesions, especially solar lentigines on the dorsum. For the cutoff in AMN-B, we chose ≥2mm, as this is widely established16,17 and our group had experience from a previous study.18

Data collection method and study variables

Data collection was performed in two phases. The first phase consisted of an interview, where inclusion and exclusion criteria were reviewed. In the second phase, patients were examined in their underwear to count AMN-B and those on the feet, including interdigital spaces and excluding areas covered by underwear and the scalp. All patients were assigned an identification number to ensure anonymity. A dermoscopic examination of all suspicious lesions was performed.

All data were collected by a previously trained dermatology resident (V.S.G.), supervised by an expert dermatologist in pigmented lesions (J.B.).

Statistical analysis

Normality of quantitative variables (age and number of AMN) was assessed using the Kolmogorov–Smirnov test. Since the number of AMN-D and AMN-S did not follow a normal distribution, the median and interquartile range [IQR] were used. The Mann–Whitney U test was used to study the relationship between qualitative and quantitative variables. Lastly, the Spearman correlation test was used to assess the relationship between quantitative variables.

Categorical variables were expressed as absolute and relative frequencies. Continuous variables were categorized for subsequent statistical analysis: age was divided into tertiles and the AMN of the feet (dorsum, sole, and interdigital) as present or absent. Binary logistic regression was used in the bivariate analysis. To quantify the size of association, the odds ratio (OR) with a 95% confidence interval (95% CI) was used. Statistically significant associations were further analyzed in a multivariate analysis, calculating the adjusted OR (aOR), with a 95% CI. Additionally, an analysis of the crude number of IDNf and the number of AMN-D and AMN-S was performed.

The level of significance for hypothesis testing was set at p<0.05. Statistical analysis was performed using SPSS software (version 25.0, IBM Corp, Armonk, NY, USA).

Results

Of the 257 subjects invited to participate in the study, 2 (0.8%) were excluded due to poor foot hygiene. Finally, a total of 255 patients who met the selection criteria were included, 51.4% of whom were women, with a median age of 53 years (Table 1).

Table 1.

Descriptive, bivariate, and multivariate analysis of the patient sample (n=255).

Explanatory variables  Total(n=255)  Result variablesBivariate analysisMultivariate analysis
    Interdigital AMN (yes)=44  Interdigital AMN (no)=211  OR (95% CI)  p-Value*  aOR (95% CI)  p-Value 
Age, n (%)
<45 years  90 (35.6)  25 (56.8)  65 (31.1)  4.2 (1.7–10.4)  0.002  0.8 (0.3–2.5)  0.71 
45–63 years  79 (31.2)  12 (27.3)  67 (32.1)  2.0 (0.7–5.3)  0.179  1.8 (0.6–5.2)  0.30 
>63 years  84 (33.2)  7 (15.9)  77 (36.8)  –  – 
Sex (male), n (%)  124 (48.6)  19 (43.2)  105 (49.8)  1.3 (0.7–2.5)  0.43     
Eye color (light), n (%)  91 (35.7)  16 (36.4)  75 (35.5)  1 (0.5–1.9)  0.92     
Hair color (light), n (%)  98 (38.4)  16 (36.4)  82 (38.9)  1.1 (0.6–2.2)  0.76     
Phototype (light), n (%)  35 (13.7)  6 (13.6)  29 (13.7)  1.0 (0.4–2.6)  0.99     
Freckles (presence), n (%)  93 (36.5)  20 (45.5)  73 (34.6)  1.5 (0.8–3.0)  0.21     
History of sunburn (yes), n (%)  137 (53.7)  24 (54.5)  113 (53.8)  1.0 (0.5–2.0)  0.95     
UVA exposure, n (%)  31 (12.2)  5 (12.3)  26 (11.4)  1.1 (0.4–3.0)  0.90     
AMN body (>50), n (%)  137 (53.7)  34 (77.3)  103 (48.8)  3.6 (1.7–7.6)  0.001  3.5 (1.5–7.9)  0.003 
AMN dorsum of the foot, median (p25–p75)  0 (0–1)  2 (1–2)  1 (1–2)    0.11     
AMN sole of the foot, median (p25–p75)  0 (0–1)  2 (1–2)  1 (1–2)    <0.001     
Presence of AMN dorsum, n (%)  118 (46.3)  24 (54.5)  94 (44.5)  1.5 (0.8–22.9)  0.23     
Presence of AMN sole, n (%)  99 (38.8)  28 (63.6)  71 (33.6)  3.5 (1.8–6.8)  <0.001  2.4 (1.2–5.1)  0.020 
Personal history of NMSC (yes), n (%)  51 (20.0)  3 (6.8)  48 (22.7)  0.3 (0.1–0.8)  0.025  0.3 (0.8–1.2)  0.09 
Personal history of MM (yes), n (%)  61 (23.9)  6 (13.6)  55 (26.1)  0.5 (0.2–1.1)  0.09  0.5 (0.2–1.3)  0.15 
History of other cancers, n (%)a  20 (7.9)  4 (9.1)  16 (7.6)  1.2 (0.4–3.8)  0.74     

Statistically significant results in bold.

NMSC: non-melanoma skin cancer; CI: confidence interval; AMN: acquired melanocytic nevi; MM: malignant melanoma; OR: crude odds ratio; aOR: adjusted odds ratio; UVA: ultraviolet A.

a

Types of cancer: breast carcinoma (n=7), prostate carcinoma (n=2), Hodgkin's lymphoma (n=2), vulvar carcinoma (n=1), colon carcinoma (n=1), acute leukemia (n=1), liposarcoma (n=1), lung carcinoma (n=1), rectal carcinoma (n=1), renal carcinoma (n=1), urinary tract carcinoma (n=1), bladder carcinoma (n=1).

*

Chi-square test (qualitative variables) or Mann–Whitney test (quantitative variables).

Table 1 presents the differences in explanatory variables based on the presence or absence of IDNf and the results of the bivariate analysis. The crude analysis showed that only patients <45 years were significantly associated with the presence of IDNf. On the other hand, no significant differences were observed regarding sex, eye color, hair color, phototype, presence of freckles, history of sunburn, UVR exposure, personal history of melanoma, or non-skin cancer. However, a personal history of NMSC showed a negative or “protective” association with the presence of IDNf.

The relationship of the presence of IDNf with variables on the number of nevi was as follows: an association was observed with the presence and number of AMN-S. Conversely, no association was observed with the presence or number of AMN-D. Similarly, a high number of AMN-B (≥50 AMN) was associated with the presence of IDNf.

Furthermore, we observed that the AMN-S count increased significantly with the IDNf count, with a correlation coefficient of 0.248 (p<0.001) (Table 2). By contrast, there was no significant correlation between the counts of AMN-D and IDNf.

Table 2.

Correlation study between the number of interdigital nevi (outcome variable) and the number of nevi on the sole and dorsum of the feet (explanatory variables).

Explanatory variable  Result variable
  No. of interdigital nevi
  r  p-Value 
No. of plantar AMN  0.248  <0.001 
No. of dorsal AMN  0.105  0.095 

Statistically significant results are shown in bold.

After multivariate analysis, the variables independently associated with IDNf were the presence of AMN-S (aOR, 2.4; 95% CI, 1.2–5.1; p=0.020) and the presence of >50 AMN-B (aOR, 3.5; 95% CI, 1.5–7.9; p=0.003) (Table 1).

Discussion

This study demonstrated that the presence of IDNf is related to the number of AMN-S, and AMN-B.

The number of skin AMN is a known risk factor for cutaneous melanoma2 and has been associated with racial phenotypic traits and SE.19–21 Counts of acral AMN, areas minimally exposed to UVR, have rarely been reported in the literature and, when present, almost exclusively refer to the soles and palms, with the dorsum not being studied.3–13 Furthermore, the interdigital spaces are even more concealed.

Finally, a total of 255 patients were included, of whom 17.3% presented IDNf. Regarding age, we observed that patients younger than 45 years had a higher risk of having IDNf. There are no studies on counts of IDNf, so the information we have is indirect from AMN-B. It has been reported that acral AMN increase during adolescence to middle age and decrease in older age.5,22 Palicka and Rhodes9 and Kogushi-Nishi et al.13 found higher prevalences of acral AMN in individuals younger than 50 years (Table 3). Similarly, the number of AMN-B follows a similar pattern.1 Although there are no specific studies on IDNf counts, in our study the highest risk of having IDNf was observed in patients younger than 45 years.

Table 3.

Comparison of the bivariate analysis results from our study with findings from the literature.

Explanatory variable  Bivariate analysis of our studyLiterature findings
  OR (95% CI)  p-Value*  Literature findings for acral AMN  Literature findings for AMN-B 
Age, n (%)
<45 years  4.2 (1.7–10.4)  0.002  Higher acral AMN counts in <50 years5,9,13,22  Higher AMN-B counts in <50 years1 
45–63 years  2.0 (0.7–5.3)  0.179     
>63 years  –     
Sex (male), n (%)  1.3 (0.7–2.5)  0.43  Contradictory results9,10,23  Contradictory results10,24,25 
Eye color (light), n (%)  1 (0.5–1.9)  0.92  No data available  Contradictory results23,26 
Hair color (light), n (%)  1.1 (0.6–2.2)  0.76     
Phototype (light), n (%)  1.0 (0.4–2.6)  0.99  Higher acral AMN counts in higher phototypes5,9,11  Contradictory results10,17,19,20,23 
Freckles (presence), n (%)  1.5 (0.8–3.0)  0.21  No data available  No data available 
History of sunburn (yes), n (%)  1.0 (0.5–2.0)  0.95  No data available  Higher AMN-B counts after sun exposure21,23,24 
UVA exposure, n (%)  1.1 (0.4–3.0)  0.90     
AMN-B (>50), n (%)  3.6 (1.7–7.6)  0.001  Contradictory results9,10,24  – 
Personal history of NMSC (yes), n (%)  0.3 (0.1–0.8)  0.025  No data available  No data available 
Personal history of MM (yes), n (%)  0.5 (0.2–1.1)  0.09  Contradictory results13,19,22  Higher AMN-B counts in patients with MM27,28 

Statistically significant results are shown in bold.

NMSC: non-melanoma skin cancer; CI: confidence interval; AMN: acquired melanocytic nevi; AMN-B: acquired melanocytic nevi of the body; MM: malignant melanoma; SE: sun exposure; OR: crude odds ratio; aOR: adjusted odds ratio; UVA: ultraviolet A.

*

Chi-square test (qualitative variables) or Mann–Whitney test (quantitative variables).

We found no significant differences in the presence of IDNf by sex. Regarding acral nevi, Palicka and Rhodes9 found higher prevalences of acral AMN in white women vs men, while other authors found no differences at all.10,23 As for the number of AMN-B, results are inconsistent, with some studies finding higher counts in men,24 others in women,25 and some finding no sex difference.10

We did not observe any relationship between IDNf counts and eye or hair color. No publications were found relating the number of acral AMN with these features. Regarding the number of AMN-B, results are inconsistent: some authors found no relationship,26 while others concluded that subjects with light eyes and hair have more AMN.23

We found no differences either with respect to the presence of IDNf and phototype or presence of freckles. As for counts of acral nevi and skin color, some authors observed that individuals with darker skin have more palmar nevi than whites, with no differences for AMN-S,5,11 while others found that the prevalence of palmar and plantar nevi increases with pigmentation.9 Regarding AMN-B counts, although some studies found more AMN in fair-skinned than in dark-skinned subjects,17,19,20,23 others found no relationship.10,24,25

We did not observe an association between IDNf and UVR exposure. As interdigital spaces are particularly covered from SE, and as AMN usually appear in sun-exposed areas,1 this lack of association seems logical. Although different patterns of ALM have been described according to location and relative sun exposure,26 nothing has been published on acral AMN in this regard. In general, it has been described that AMN-B increase after SE.21,23,24

The presence of IDNf was significantly associated with a higher risk of elevated AMN-B count. Counts of acral AMN have been associated with higher AMN-B counts,9,24 although other studies have not found this association.10 As for the relationship with acral AMN count, bivariate analysis showed that the presence of IDNf was associated with a greater risk of having an AMN-S, whereas IDNf were not related to AMN-D.

The presence of IDNf was associated with a lower risk of having NMSC. This protective role could be explained by the fact that IDNf, being in covered areas (unlike most NMSC), have different pathogenic factors. On the other hand, we found no reports in the literature linking acral nevus counts and NMSC.

Another notable finding is that the presence of IDNf was not associated with a personal history of melanoma. The relationship between the number of AMN-S and the past medical history of melanoma varies in the literature. Some studies found no difference in the prevalence of AMN-S between plantar melanoma cases and controls13; others have associated ALM with high counts of AMN-S,16 and others concluded that AMN count is an important risk factor for non-acral melanoma, but not for ALM.22 In general, it has been demonstrated that high AMN-B counts are associated with a high risk of melanoma.27,28

Finally, in multivariate analysis, the only two variables that independently explained the presence of IDNf were the presence of AMN-S and the presence of >50 AMN on the body. We hypothesize that this association between IDNf and plantar nevi may be due to the anatomical similarity of interdigital spaces to the soles, making them an extension of the sole. The absence of relationship with AMN-D suggests that other anatomical, genetic, or even photoexposure factors may influence the development of AMN-D, but not AMN-S or IDNf.

The relationship between site-specific nevus count and AMN-B has been described several times.29 The best correlations have been found for the number of nevi on the forearm and thigh. We found no studies specifically addressing IDNf. However, Papageorgiou et al.10 detected a relationship between the presence of acral nevi and elevated AMN-B counts, consistent with our findings between IDNf and AMN-B.

On the other hand, acral AMN and ALM do not seem to have a direct relationship.30 The two entities have independent clinical and histopathological characteristics, and a different mutational profile, suggesting that ALM arise mostly de novo, not from AMN.

Regarding the examination of interdigital spaces, we think it is not routinely performed in daily practice, which could delay the diagnosis of malignant disease. In fact, in our study we detected one case of in situ interdigital ALM the patient was unaware of.31

As for the study limitations, it is a single-center study with a small sample size, which limits its external validity.

In conclusion, the presence of IDNf is associated with a higher number of AMN-S and AMN-B. As far as we know, this is the first published study on IDNf, providing a new epidemiological perspective on acral nevi in an area of the body without SE, such as interdigital spaces. Furthermore, the association we observed between the presence of IDNf and the number of AMN-B is possibly due to genetic factors, and not only environmental factors such as SE, influencing the number of AMN.

Funding

None declared.

Conflicts of interest

None declared.

References
[1]
A. Hauschild, F. Egberts, C. Garbe, J. Bauer, S. Grabbe, H. Hamm, et al.
Melanocytic nevi.
J Dtsch Dermatol Ges, 9 (2011), pp. 723-734
[2]
H.A. Haenssle, N. Mograby, A. Ngassa, T. Buhl, S. Emmert, M.P. Schön, et al.
Association of patient risk factors and frequency of nevus-associated cutaneous melanomas.
JAMA Dermatol, 152 (2016), pp. 291-298
[3]
S. Park, S.J. Yun.
Acral melanocytic neoplasms: a comprehensive review of acral nevus and acral melanoma in Asian perspective.
Dermatopathology (Basel), 9 (2022), pp. 292-303
[4]
A. Kukita, K. Ishihara.
Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan.
J Invest Dermatol, 92 (1989), pp. 210S-213S
[5]
E.J. Van Scott, R.P. Reinertson, C.B. Rigcall.
Prevalence, histological types, and significance of palmar and plantar nevi.
[6]
F.C. Wilson, P.C. Anderson.
A dissenting view on the prophylactic removal of plantar and palmar nevi.
[7]
S.I. Cullen.
Incidence of nevi report of survey of the palms, soles, and genitalia of 10,000 young men.
[8]
B. Allyn, A.W. Kopf, M. Kahn, V.H. Witten.
Incidence of pigmented nevi.
[9]
G.A. Palicka, A.R. Rhodes.
Acral melanocytic nevi: prevalence and distribution of gross morphologic features in white and black adults.
Arch Dermatol, 146 (2010), pp. 1085-1094
[10]
C. Papageorgiou, A. Kyrgidis, P.A. Ilut, T. Gkentsidi, S.M. Manoli, E. Camela, et al.
Acral melanocytic nevi in a high-risk population: prevalence clinical characteristics and dermatoscopic patterns.
Dermatology, 239 (2023), pp. 753-759
[11]
R. Madankumar, P.V. Gumaste, K. Martires, P.R. Schaffer, S. Choudhary, L. Falto-Aizpurua, et al.
Acral melanocytic lesions in the United States: prevalence, awareness, and dermoscopic patterns in skin-of-color and non-Hispanic white patients.
J Am Acad Dermatol, 74 (2016),
[12]
M. Wawrzynkiewicz, M. Pastuszczak, M. Chlebicki, A. Wojas-Pelc.
Acral melanocytic nevi in the Polish population: prevalence, clinical characteristics and dermoscopic patterns.
Postepy Dermatol Alergol, 36 (2019), pp. 581-588
[13]
H. Kogushi-Nishi, J. Kawasaki, T. Kageshita, T. Ishihara, H. Ihn.
The prevalence of melanocytic nevi on the soles in the Japanese population.
J Am Acad Dermatol, 60 (2009), pp. 767-771
[14]
P. Jansen, I. Cosgarea, R. Murali, I. Möller, A. Sucker, C. Franklin, et al.
Frequent occurrence of NRAS and BRAF mutations in human acral naevi.
Cancers (Basel), 11 (2019), pp. 546
[15]
G.C. Leonardi, L. Falzone, R. Salemi, A. Zanghì, D.A. Spandidos, J.A. Mccubrey, et al.
Cutaneous melanoma: from pathogenesis to therapy (review).
Int J Oncol, 52 (2018), pp. 1071-1080
[16]
A. Green, M. McCredie, R. MacKie, G. Giles, P. Young, C. Morton, et al.
A case–control study of melanomas of the soles and palms (Australia and Scotland).
Cancer Causes Control, 10 (1999), pp. 21-25
[17]
R.P. Gallagher, D.I. McLean, C.P. Yang, A.J. Coldman, H.K. Silver, J.J. Spinelli, et al.
Anatomic distribution of acquired melanocytic nevi in white children: a comparison with melanoma: the Vancouver mole study.
Arch Dermatol, 126 (1990), pp. 466-471
[18]
J. Bañuls, J.M. Climent, J. Sánchez-Payá, R. Botella.
The association between idiopathic scoliosis and the number of acquired melanocytic nevi.
J Am Acad Dermatol, 45 (2001), pp. 35-43
[19]
A. Green, R. Maclennan, V. Siskind.
Common acquired naevi and the risk of malignant melanoma.
Int J Cancer, 35 (1985), pp. 297-300
[20]
F.H.J. Rampen, H.L.M. van der Meeren, J.B.M. Boezeman.
Frequency of moles as a key to melanoma incidence?.
J Am Acad Dermatol, 15 (1986), pp. 1200-1203
[21]
L.K. Dennis, E. White, J.A.H. Lee, A. Kristal, B. McKnight, P. Odland.
Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study.
Am J Epidemiol, 143 (1996), pp. 248-256
[22]
S. Rokuhara, T. Saida, M. Oguchi, K. Matsumoto, S. Murase, S. Oguchi.
Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.
J Am Acad Dermatol, 50 (2004), pp. 695-700
[23]
M. Dulon, M. Weichenthal, M. Blettner, M. Breitbart, M. Hetzer, R. Greinert, et al.
Sun exposure and number of nevi in 5- to 6-year-old European children.
J Clin Epidemiol, 55 (2002), pp. 1075-1081
[24]
P. Aguilera, S. Puig, A. Guilabert, M. Julià, D. Romero, A. Vicente, et al.
Prevalence study of nevi in children from Barcelona. Dermoscopy, constitutional and environmental factors.
Dermatology, 218 (2009), pp. 203-214
[25]
R.M. MacKie, J. English, T.C. Aitchison, C.P. Fitzsimons, P. Wilson.
The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population.
Br J Dermatol, 113 (1985), pp. 167-174
[26]
A.M. Haugh, B. Zhang, V.L. Quan, E.M. Garfield, J.A. Bubley, E. Kudalkar, et al.
Distinct patterns of acral melanoma based on site and relative sun exposure.
J Invest Dermatol, 138 (2018), pp. 384-393
[27]
D.R. English, B.K. Armstrong.
Identifying people at high risk of cutaneous malignant melanoma: results from a case–control study in Western Australia.
Br Med J (Clin Res Ed), 296 (1988), pp. 1285-1288
[28]
Y.M. Chang, J.A. Newton-Bishop, D.T. Bishop, B.K. Armstrong, V. Bataille, W. Bergman, et al.
A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.
Int J Cancer, 124 (2009), pp. 420-428
[29]
D. Jayasinghe, K.L. Nufer, B. Betz-Stablein, H.P. Soyer, M. Janda.
Body site distribution of acquired melanocytic naevi and associated characteristics in the general population of Caucasian adults: a scoping review.
Dermatol Ther (Heidelb), 12 (2022), pp. 2453-2488
[30]
E. Nagore, C. Pereda, R. Botella-Estrada, C. Requena, C. Guillén.
Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility.
Cancer Causes Control, 20 (2009), pp. 115-119
[31]
J. Bañuls.
Strategies for reducing diagnostic delay in acral lentiginous melanoma.
Actas Dermosifiliogr, 109 (2018), pp. 764
Copyright © 2024. AEDV
Descargar PDF
Idiomas
Actas Dermo-Sifiliográficas
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?